NANJING, China — Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the 6th China International Import Expo (CIIE) with FUCASO, the world’s first fully-human CAR-T, and entered into a strategic partnership with several international medical institutions, bringing hope for cure to multiple myeloma (MM) patients worldwide. On JuneContinue Reading
On June 8, 2023 in Dubai UAE the legendary annual business award ceremony “Mrs lady of the year middle east 2023” took place at the luxurious Dusit Thani Hotel. 20 participants were selected from 80 business ladies. Natalia Belinskaya was a finalist and winner of the event and was awarded.Continue Reading
WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology, neurology, and virology announced today its intention to study potential therapeutic use of its investigational COVID-19 T cell therapy, TVGN-489, in Long COVID. The finding that none of the patients in theContinue Reading
